Our Team

Tom Forte

Tom Forte has over 30 years of diverse business experience, roles, and leadership assignments in human and animal healthcare. He has successfully transformed teams, cultures, operating models, and value propositions to improve competitive differentiation and better serve customers – resulting in a consistent delivery of financial, new-logo, and market-share growth objectives. Most recently he served as President of Covetrus North America, a >$2.7B business, with a mission of ensuring their portfolio of technology, service, and product solutions help veterinarians drive better outcomes. His prior roles include Chief Commercial Officer at Covetrus North America and extensive sales, marketing, and other commercial leadership positions at Pfizer Inc, Pfizer Animal Health (Zoetis), and Johnson & Johnson. He served on the boards of Veterinary Study Groups, Animalytix, and United Veterinary Services Association. Tom graduated from the University of Tennessee Knoxville with a Bachelor of Science degree in Business Administration.

Curt Boisfontaine

Curt Boisfontaine founded Meridian in 1994 and has been involved in the investment business since 1982. He is currently the sole Director of Meridian’s entities and is President of Meridian Capital Corporation. In 2016, following a 25-year history of investing in human healthcare related real estate projects, he became intrigued with animal healthcare and Meridian pivoted its investment focus to the veterinary industry. Since that time, Meridian has assembled a portfolio of veterinary specialty hospitals which provide advanced animal healthcare capabilities worth approximately $200M. Curt serves on the board of directors of Operation Kindness, a Dallas based not-for-profit animal welfare organization and operates a lifesaving animal shelter and offers programs to assist people and pets. Curt was raised in New Orleans, LA and completed his formal education in 1981 at Tulane University, where he studied economics.

David Ronck

David Ronck is the President of Meridian and oversees all aspects of the day-to-day business. He brings more than 25 years of operational, financial and capital markets experience to LexaGene. Since joining Meridian in 1995, David has held numerous positions during his tenure and has been responsible for project capitalization and financing for Meridian’s veterinary hospitals and other Meridian projects. He and Curt Boisfontaine are the two principal partners of the company and Meridian’s various investment partnerships and operational entities. He holds a Bachelor of Science degree in Accounting from Oklahoma State University, currently serves as the governor of the university's foundation and is a Certified Public Accountant in the State of Texas.

Dr. Jack Regan

Dr. Regan is the inventor of the LexaGene automated pathogen detection system, MiQLab®. Before founding LexaGene, he led a team of scientists at Bio-Rad Laboratories in developing tests for detecting pathogens, cancer, and neurological disorders using droplet digital PCR. Prior to Bio-Rad, Jack helped QuantaLife, a startup company, bring its product from concept to commercialization, where it was subsequently acquired by Bio-Rad. He has also worked at Applied Biosystems/Life Technologies on automated sample preparation and did his post-doctoral training at Lawrence Livermore National Laboratory, where he developed automated instruments to detect respiratory pathogens and biothreat agents for the US government’s BioWatch program. His doctoral training at the University of California San Francisco focused on influenza viral replication.

Miles Blanton

Miles Blanton joined Meridian in April 2013. He has the overall responsibility of the accounting and financial reporting functions of all of Meridian’s companies. Prior to Meridian, he worked for various national home health agencies and skilled nursing operators. These companies range in size from $30 million to $350 million in revenue. Miles graduated from Texas A&M University in May 1993 with a bachelor’s degree in accounting. Since that time, he has spent the majority of his career in the health care industry.